NSE: LAURUSLABS · 28 October 2026
- Laurus Labs has risen 10.76% over 3 trading sessions; today's move is +1.86%.
- Laurus Labs announced that CARE ESG Ratings Limited assigned an Environmental, Social, and Governance score of 82.6 with a CareEdge-ESG 1+ rating symbol. The rating reflects the company's performance in managing ESG risks through established disclosures and policies. This provides institutional context on the company's governance and sustainability positioning.
- Trading volume was 1.34 times the 20-day average daily volume.
Laurus Labs share price: 10.76% rise over 3 trading sessions
Laurus Labs Limited shares advanced 1.86% on Tuesday, closing at ₹2,181.90 after moving within a day's range of ₹2,135.50 and ₹2,198.80.
While the broader Nifty index dipped 0.22%, the sector benchmark Nifty Pharma rose 1.04%, indicating positive momentum across pharmaceutical equities. Laurus Labs outperformed the broader index while moving in tandem with its sectoral peers, building upon recent gains that brought its 5-day return to 8.42% and its 20-day return to 8.51%.
Company developments during recent weeks include an intimation regarding a CARE Edge ESG rating of 'CareEdge-ESG 1+' with a score of 82.6, alongside equity investments via rights issues in KRKA Pharma Private Limited and Kurnool Renewables Private Limited. While these updates highlight ongoing corporate developments and sustainability scoring, no single catalyst was directly tied to today's positive price action, which appears consistent with steady sector strength and ongoing momentum following recent sessions.
20.89 lakh shares traded by 28 October 2026 · 03:15 PM IST. This compares with a 20-day average daily volume of 15.60 lakh shares (1.34 times). The five-day average daily volume was 19.37 lakh shares. Separately, the NSE report for 27 October 2026 showed 14.81 lakh shares delivered, representing 47.51% of that day’s traded volume. The same report recorded 72,696 trades.
The stock advanced alongside the positive Nifty Pharma sector benchmark, supported by above-average trading volume and sustained buying interest following recent sessions. No new corporate announcement or same-day catalyst was explicitly linked to today's move.
Latest Company Developments
Laurus Labs announced that CARE ESG Ratings Limited assigned an Environmental, Social, and Governance score of 82.6 with a CareEdge-ESG 1+ rating symbol. The rating reflects the company's performance in managing ESG risks through established disclosures and policies. This provides institutional context on the company's governance and sustainability positioning.
Demonstrates independent validation of sustainability and governance standards, relevant for ESG-focused institutional investors.
The company invested ₹107.80 crore to acquire 10,78,00,000 equity shares of KRKA Pharma Private Limited at face value via a rights issue. Consequent to this investment, Laurus Labs' total holding stands at 26,21,50,000 equity shares, maintaining its 49% stake in the joint venture.
Expands capital commitment in a key joint venture entity without altering ownership proportion.
Laurus Labs invested ₹12.10 crore to acquire 1,20,96,050 equity shares of Kurnool Renewables Private Limited through a rights issue. Following this transaction, the company's total holding reached 2,11,68,000 equity shares, keeping its associate shareholding steady at 26%.
Secures renewable power sourcing commitments supporting long-term operational cost efficiency and sustainability targets.
Laurus Labs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 8.26% on 30 September 2026. This compares with 10.15% on 30 June 2026, a change of -1.89 percentage points.
The filing reported 38 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Upcoming board meeting scheduled for October 29, 2026, to consider un-audited financial results for the quarter and half-year ended September 30, 2026, and potential interim dividend payment.
- Execution progress and capacity scaling across new manufacturing assets and growth capital expenditure projects in API, FDF, and advanced modalities.
- Delivery percentages and volume sustainability relative to the 20-day average volume of 1.34x.
- Broader performance of the Nifty Pharma index and sector-level sentiment trends.
Other Dated Coverage
- Laurus Labs Share Price Today: Why LAURUSLABS Is Rising 4.04% | 27 October 2026 — 27 October 2026
- Laurus Labs Share Price Today: Why LAURUSLABS Is Falling 1.94% | 23 October 2026 — 23 October 2026
- Laurus Labs in Focus After Receiving CareEdge-ESG 1+ Leadership Rating | 16 October 2026 — 16 October 2026
More Laurus Labs news and dated analysis →
Frequently Asked Questions
What is the latest Laurus Labs company news?
Laurus Labs announced that CARE ESG Ratings Limited assigned an Environmental, Social, and Governance score of 82.6 with a CareEdge-ESG 1+ rating symbol. The rating reflects the company's performance in managing ESG risks through established disclosures and policies. This provides institutional context on the company's governance and sustainability positioning.
How strong was Laurus Labs’s trading volume?
20.89 lakh shares traded, 1.34 times the 20-day average daily volume. The price and volume data are dated 28 October 2026 · 03:15 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.